181 related articles for article (PubMed ID: 35363249)
1. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.
Holzman SB; Perry A; Saleeb P; Pyan A; Keh C; Salcedo K; Narita M; Ahmed A; Miller TL; Pettit AC; Khurana R; Whipple M; Katz D; Largen A; Krueger A; Shah M;
Clin Infect Dis; 2022 Nov; 75(10):1792-1799. PubMed ID: 35363249
[TBL] [Abstract][Full Text] [Related]
2. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic.
Shah M; DiPietro D; Greenbaum A; Ketemepi S; Martins-Evora M; Marsiglia V; Dorman SE
PLoS One; 2012; 7(5):e36551. PubMed ID: 22586476
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
[TBL] [Abstract][Full Text] [Related]
4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
5. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Latent Tuberculosis Infection in the United States.
Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
[TBL] [Abstract][Full Text] [Related]
7. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
8. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
[TBL] [Abstract][Full Text] [Related]
9. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
11. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
12. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
13. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
14. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
15. Emergency department screening for latent tuberculosis infection.
Faryar KA; Braun R; Ancona RM; Ajayi E; Bryant W; Rehman S; Sall H; Lyons MS; Huaman MA
Am J Emerg Med; 2022 Apr; 54():323.e5-323.e8. PubMed ID: 34756647
[TBL] [Abstract][Full Text] [Related]
16. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
19. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
20. Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
Uzorka JW; Duinkerk DL; Kroft LJM; Bakker JA; Ramai RSRS; Ottenhoff THM; Arend SM
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1329-1337. PubMed ID: 32076881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
